Joe Raedle/Getty Images Noah, a 2-year-old from Middlefield, Connecticut, is starting daycare next month. His mother, Carolyn Janis, is anxious. Noah is allergic to eggs, peanuts, and other nuts. It's compounded by severe asthma. Janis has four EpiPens for her son that are past their expiration date, and one with its expiration coming up soon. He needs a new one for daycare, but she's not sure if she can afford it. Janis's health insurance changed recently. She and her family are on a high-deductible healthcare plan. She's already exhausted her health savings account this year, and she's still paying off emergency-room visits from a year and a half ago. Add to that the fact that the list price of the EpiPen has exploded to more than $600 over the past decade . Janis is one of thousands of people who are unsure about whether they'll be able to have on hand the life-saving medication they need for themselves or their loved ones. It's a result of some of the worst parts of the government and the US healthcare system coming together over the past decade. "I'm a nervous wreck," Janis said. "I know that this is all part of society. But so much of me wants to just hold him back." ••• Let's start off with a disclosure : Like it is for Noah, an EpiPen is one of the most important features of my life. I'm allergic to peanuts. If I happened to eat something that contained a [...]